Department of HEI - Health Research Methodology Logo


The Graduate Diploma in Clinical Epidemiology Program now has its own website!

The Health Research Methodology (HRM) Program in the Faculty of Health Sciences provides training at the MSc and PhD level. The goal is to produce graduates with research methods skills that enable them to “push the boundaries of knowledge” relevant to improving clinical practice (including medical education research), strengthening health systems and enhancing population health. 

The HRM Program celebrates over 40 years of excellence and innovation in the training of clinical epidemiologists and health systems researchers.  

For more information on the HRM Program please visit the About Us page. 

Seven projects led by Faculty of Health Sciences (FHS) researchers received $61 million from the Canadian Institutes of Health Research (CIHR) to advance medical research, training and innovation.

The funding was announced on Jan. 19 at McMaster University by Filomena Tassi, MP for Hamilton West-Ancaster-Dundas and minister responsible for the Federal Economic Development Agency for Southern Ontario, as part of CIHR’s Clinical Trials funding initiative.

The stories on all seven FHS research projects can be found here:

Deborah Cook received an additional $1.9 million for an ongoing global trial to test the effectiveness of an ulcer-suppressing drug in patients in the intensive care unit.

P.J. Devereaux, co-lead for the Pan-Canadian Accelerating Clinical Trials Consortium, received $39 million to expand its clinical trial networks, support clinical trial units and improve collaboration and knowledge sharing.

Kim Lewis received $3.7 million for an international pragmatic randomized control trial focused on non-invasive ventilation in the critically ill.

Sameer Parpia received more than $2.5 million in federal funding to help plug a critical shortage of clinical trial biostatisticians using a Canada-wide training platform.

Jason Roberts is tackling a lethal genetic heart condition with a potentially revolutionary treatment, helped by $2.7 million in funding.

Bram Rochwerg received $3.4 million to test a potentially life-saving therapy for people experiencing acute breathing difficulty.

Fiona Smaill received $8.2 million for Phase 2 human trials to evaluate the safety and efficacy of a next-generation COVID-19 vaccine delivered by inhaled aerosol.

The Brighter World story of the announcement itself can be found here.

    No items to display

Accessibility for Ontarians With Disabilities Act (AODA)


The Faculty of Health Sciences is committed to providing a website that is accessible to the widest possible audience. If there is an accessibility issue with this website, please contact us at